Horizon Pharmaceutical 10K 2012 Annual report | SEC Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: absent, accommodate, acid, adjudication, advocacy, afflicted, Alex, Alexion, ALXN, amino, Aon, Appl, artemisinin, ATM, attenuated, BDNF, Beal, bioengineered, BioSource, blinded, bond, breath, Bristol, broadly, Brown, Budget, budgetary, burden, burn, CAG, Carolina, cast, caution, cessation, chose, closer, commodity, commuting, concomitant, concomitantly, conflict, conventional, coordinating, Cornell, COU, coupled, CRADA, CRF, cultural, culture, CV, CyNCh, Cystadane, cysteine, debilitating, defraud, degeneration, dehydration, delineated, depth, diagnosed, dietary, disagree, disrupted, dossier, Doude, Dutch, egg, elevated, encompassing, Enobia, equate, Erbez, error, exhaled, extracellular, extracted, extraordinary, facial, Fanconi, fibrotic, formulae, fraudulent, Genzyme, Georgia, glutathione, GSH, Hambrecht, Hawaii, hedge, Henk, hereditary, histological, Honolulu, Hospitalier, hour, hub, hypothetical, hypothyroidism, idle, imprisonment, indebted, infused, insert, instance, intake, intervention, intracellular, inventory, irrespective, Ithaca, Jazz, Keller, knowingly, language, Laval, leadership, Levtchenko, link, lump, macroeconomic, mailing, main, malaria, markedly, McGill, MINE, miscommunication, misdiagnosed, modification, Montreal, MOU, mouse, multicenter, myopathy, Myozyme, NAS, nausea, negating, Nephrol, nerve, neuron, neuronal, neurotrophic, NIDDK, night, nighttime, NOL, odor, oxidized, parasite, parasitic, pathophysiology, payor, PDUFA, pegylated, pension, percentile, photophobia, poor, Portability, powder, PPI, precursor, preparatory, prerequisite, preset, pretax, privacy, PROCYSBI, Promedior, proportional, quantifiable, Quebec, Quist, Radford, ranked, RaptorCaresTM, RDT, recapture, red, referral, regimen, registry, relocate, relocation, remuneration, renal, rescuing, residence, respiratory, Rett, robust, rotten, scenario, scheme, SCRI, Seattle, shift, Shortly, skilled, skipping, sleep, smell, Smith, socially, solvency, span, Squib, Statute, Stewart, strict, struggle, Suboptimal, Sunshine, tablet, thirst, thrive, Troostwijk, tube, UBC, unaffected, underway, uninterrupted, Universit, Universitaire, unrealized, unsatisfied, unusual, upheld, urgent, urination, version, visible, voluntarily, vomiting, Wall, Wanger, weather, webcasting, widespread, worst, worth, XBRL

Removed: accountant, activate, acute, AMPA, annum, antagonist, assign, attestation, beneficially, bid, binding, block, buy, call, certified, collaborating, complexity, concept, Craig, dedicated, delivering, diminish, document, dosed, efficient, Elan, examination, expired, expiring, feet, formed, fourth, furniture, glutamate, impede, inconclusive, internally, internet, la, licensee, LP, mg, multiplying, neurologic, OTC, partnering, partnership, penny, peptide, Plant, play, preclude, produced, promoting, proof, recruiting, reincorporated, removed, repaid, replicate, reserved, revert, select, shared, show, sought, square, studying, subtype, unacceptable, unmet


NAME OF SUBSIDIARY		JURISDICTION OF INCORPORATION
Raptor Discoveries Inc., wholly-owned subsidiary of Registrant		Delaware, United States
Raptor Therapeutics Inc., wholly-owned subsidiary of Registrant		Delaware, United States
Raptor Pharmaceuticals Europe B.V., wholly-owned subsidiary of RPTP European Holdings C.V.		The Netherlands
Raptor European Products, LLC, wholly-owned subsidiary of Raptor Therapeutics Inc.		Delaware, United States
RPTP European Holdings C.V., wholly-owned subsidiary of Raptor Therapeutics Inc. and Raptor European Products, LLC		Registered in the Netherlands, business office in Grand Cayman

Horizon Pharmaceutical 10-K2012 FY Annual report

Content analysis